AXIC-A aXichem AB (publ)
aXichem AB (publ), a biotechnology company, engages in the development of natural analogue ingredients in Sweden. The company offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen, a solution for improved health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is based in Malmö, Sweden.…
Industry Peers
Specialty ChemicalsKey Statistics
About aXichem (STO: AXIC-A)
›
aXichem (STO: AXIC-A) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 7 employees.
The shares were at 1.645 SEK on 19 November 2026, down 36.5% over 52 weeks. Its 52-week range is 1.135 SEK to 4.000 SEK: the price is 58.9% below the high and 44.9% above the low.
Its market capitalisation is 111.41M SEK.
aXichem reports return on equity of -33.4%, an operating margin of -94.2% and revenue down 39.4% year over year.
It holds more cash than debt, a net cash position of 2.28M SEK. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.